Business

Business

Molina Healthcare is a US-listed (NYSE: MOH) government-sponsored managed-care insurer — Medicaid, Medicare duals, and ACA Marketplace — serving roughly 5.5 million members across 21 states on $45.4 billion of FY2025 revenue, founded in 1980. Its ~$11.9 billion market cap clears the framework's $10 billion floor, if by a slim margin. The industry is a consolidated oligopoly of a handful of national plans sitting behind state licensing and statutory-capital barriers. It is no auto-OEM, carries no China exposure, and — down two-thirds from its 2024 peak with a Hold-rated tape — screens as an out-of-favour name, not a consensus darling.

What Molina does

Molina Healthcare, a FORTUNE 500 company, sells managed healthcare under government programs: Medicaid, Medicare, and the state insurance marketplaces. It was founded in 1980 as a provider organization serving low-income families in Southern California and reincorporated in Delaware in 2002; it served approximately 5.5 million members across 21 states as of December 31, 2025 [1]. The model is simple to state: state and federal agencies pay Molina a fixed per-member premium to take on the medical risk of a defined population, and Molina profits when the care it arranges costs less than the premium it collects. Essentially all of its revenue is premium from those government contracts — $43.05 billion of the $45.43 billion FY2025 total [2].

In two sentences: Molina is a pure-play government-managed-care company that rents its balance sheet and provider networks to states and to CMS, insuring people who qualify for Medicaid, dual-eligible Medicare, and subsidized exchange coverage. It earns a thin spread on a very large premium base — net margin was roughly 1% in FY2025 — so results are governed by one ratio, the share of each premium dollar spent on medical care.

Sources: FY2025 Form 10-K, Item 1 Business [3] and Human Capital [4]; market cap from fit_features (52.9M shares x $224.82 close, 2026-07-16).

Segments and their economics

Molina reports four segments — Medicaid, Medicare, Marketplace, and an insignificant Other — all but the last representing government-funded programs [5]. Medicaid is the core: three-quarters of premium and 83% of members. Medicare skews to higher-acuity dual-eligible members, and Marketplace grew sharply in 2025 on pricing strategy and the ConnectiCare acquisition.

Source: FY2025 Form 10-K — segment membership and premium revenue [6]; medical margin and MCR by segment [7].

The "medical care ratio" (MCR) — medical costs as a percentage of premium — is the whole game. Across the book it ran 91.7% in FY2025, up 260 basis points from 89.1% the year before, and it rose in every segment: Medicaid 90.3% to 91.8%, Medicare 89.1% to 92.4%, and Marketplace from 75.4% to 90.6% [8]. Because the residual margin is so thin, that move compressed total medical margin from $4.20 billion to $3.56 billion and roughly halved earnings. Management attributes it to medical cost trend outrunning the rates states have granted, a "rate and trend imbalance that we believe to be temporary" [9]. Whether that imbalance is temporary or a permanent reset in the economics is the question the Damage Math and Dislocation tabs carry.

Scale and trajectory

Revenue has compounded from $16.8 billion in FY2019 to $45.4 billion in FY2025 — contract wins, redetermination-era Marketplace inflows, and acquisitions (ConnectiCare, closed February 2025). Earnings tell a different, more recent story: net income of $472 million in FY2025 against $1,179 million in FY2024, and diluted EPS of $8.92 against $20.42 [10].

Source: reported financials, FY2019–FY2025 Form 10-Ks; FY2025 figures per Item 1 Business — Financial Highlights [11].

Geographically the footprint is entirely domestic — 21 US states, from Washington and California to Texas, Florida, New York, and New England — with no foreign operations and no revenue outside US government programs [12]. The workforce numbered approximately 19,000 at year-end 2025 [13].

Market structure

The framework's durability gate leans on market structure, so it is worth laying the evidence out plainly. US managed care is an oligopoly of large national plans, and Molina competes against the same short list across its lines. In Medicaid, its 10-K names its "primary competitors" as Centene Corporation, CVS Health Corporation, Elevance Health, UnitedHealth Group, and large not-for-profit organizations, and flags "increasing competition driven by renewed interest from large national health plans" [14]. In Medicare it lists CVS Health, Humana, and UnitedHealth as the large competitors; in Marketplace, its "primary competitor for low-income Marketplace membership is Centene Corporation" [15]. This is not a fragmented cottage industry; it is a handful of scaled players bidding for the same state contracts.

Molina is the smallest of the publicly traded national managed-care organizations by revenue, a specialist among diversified giants. That relative size cuts both ways for durability: it is a genuine top-tier Medicaid operator, but it lacks the pharmacy, provider, and commercial diversification of the larger names.

Source: reported FY2025 revenue per each company's latest annual report / data feed; CVS Health (Aetna), also a named competitor, is omitted for a clean revenue comparison but exceeds Molina many times over. Named peer set per Molina FY2025 Form 10-K [16].

Entry barriers, capital intensity, and how long it has run

Three structural features do the durability work here, and each is documented.

Regulatory entry barriers. A new entrant cannot simply undercut on price. To operate, a plan must obtain a state certificate of authority, build a provider network, stand up claims systems, and — critically — win a competitively bid state contract; states award those contracts on network, quality of service, care-management capability, member satisfaction, reputation, and financial resources, and even an incumbent is not guaranteed a renewal at rebid [17]. Molina's own filing calls the start-up cost of a new health plan "substantial," itemizing the certificate of authority, provider network, infrastructure, and "significant capital to fund mandated net worth requirements, performance bonds or escrows, or contingency guaranties" [18].

Capital intensity as a moat. Each health-plan subsidiary is licensed by a state insurance department (or, in California, the Department of Managed Health Care) and must hold a minimum amount of statutory capital fixed by statute or regulation, with restrictions on paying that capital up to the parent [19]. The regulated subsidiaries paid $985 million of dividends up to the parent in 2025, and the parent contributed $439 million of capital back down — the machinery of a regulated-capital business, not a capital-light one [20].

A long operating history and an essential product. Molina has run health plans for 45 years, since 1980 [21], and the product — health coverage for low-income and dual-eligible populations — is about as non-discretionary as spending gets, delivered under multi-year government contracts.

The structure has hardened over time. At its 2003 IPO, Molina described the Medicaid managed-care industry as "highly fragmented," citing CMS data of "over 500 Medicaid managed care contractors nationwide" as of mid-2001 [22]. Twenty-two years later the same company names five or six national plans as its principal competitors — evidence of consolidation into an oligopoly, the raw material the Durability tab weighs.

Universe screen

Geography (U1). Molina is a US company incorporated in Delaware, with common stock listed directly on the New York Stock Exchange under ticker MOH — not an ADR, not a Chinese issuer [23]. The geography screen is a clean pass.

Market capitalization (U2). On the feature file's snapshot — 52.9 million shares at the $224.82 close of 2026-07-16 — market cap is $11.89 billion, above the $10 billion line but by only about 19%. The proximity is real and worth stating: the stock is one bad print from the floor. At its February 2026 trough of $122.65 the same share count implies a cap near $6.5 billion, well below the threshold, and current sell-side coverage (as of late June / mid-July 2026) rates the shares a consensus Hold with an average price target around $190–211, roughly at or below the current price — a neutral tape, not an excited one. The screen is met on today's price, but it is a live consideration rather than a settled one.

Source: market cap derived from fit_features (shares x close); peak $360.77 (2024-09-16) and trough $122.65 (2026-02-11) from the price series; the $10B line is the framework's universe floor. Listing facts per FY2025 annual report cover [24].

First-pass exclusion screen

Auto-OEM (X1). Not applicable. Molina is a government-sponsored managed-care insurer; it manufactures nothing and has no automotive exposure. The exclusion does not fire.

Consensus-saturated darling (X4). This is the opposite of a darling. On $45.4 billion of revenue and an $11.9 billion cap the shares trade at roughly 0.26x sales — the razor-thin-margin multiple of an insurer, not the multiple-to-sales of a story stock. The chart shape is a two-thirds drawdown (down 66% from the September 2024 peak to the February 2026 trough), the sell side rates it Hold (of the last polled coverage, 3 buy / 15 hold / 1 strong-sell) with the price already at or above the average target, and consensus forward EPS has been cut hard — the FY2026 estimate near $5.16 against $11.03 a year earlier. Nothing here resembles a consensus-owned, extreme-multiple darling; the exclusion does not fire.

China dependence (S1). Absent. Molina's revenue is entirely US government-program premium across 21 US states, with no foreign operations and no China revenue or asset exposure to quantify [25]. The sensitivity flag is not raised.